Study Design: Retrospective analysis of a Medicare database (2005 to 2012).

Objective: To study postoperative complication rates following thoracolumbar fusion for traumatic thoracolumbar fracture in patients with ankylosing spondylitis (AS) compared with patients without AS.

Methods: The PearlDiver database (2005 to 2012) was queried to examine postoperative complication rates in patients with AS undergoing posterior thoracolumbar fusion for thoracolumbar fracture (  =  968). Complication rates were compared with proportion-matched controls without AS undergoing the same procedure (  =  1,979). We examined and compared the incidence of death, postoperative infection, transfusion, venous thromboembolism, respiratory failure, pneumonia, myocardial infarction, urinary tract infection, and acute renal failure in each cohort within 90 days postoperatively.

Results: Patients with AS had significantly higher rates of surgical site infection (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.2 to 2.2,   =  0.002), day-of-surgery transfusion rates (OR 1.5, 95% CI 1.3 to 1.8,  < 0.0001), respiratory failure (OR 1.8, 95% CI 1.3 to 2.5,   =  0.0006), pneumonia (OR 1.8, 95% CI 1.3 to 2.5,   =  0.0002), acute renal failure (OR 1.6, 95% CI 1.2 to 2.3,   =  0.005), and total medical complications (OR 1.5, 95% CI 1.2 to 1.9,  < 0.0001). Ninety-day mortality was not different between the two cohorts (  =  0.18).

Conclusions: Thoracolumbar fusion for thoracolumbar fracture in patients with AS is associated with increased rates of surgical site infection, transfusion, respiratory failure, pneumonia, and acute renal failure postoperatively compared with patients without AS. The level of evidence in this study was III.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400163PMC
http://dx.doi.org/10.1055/s-0036-1583175DOI Listing

Publication Analysis

Top Keywords

complication rates
12
fusion thoracolumbar
8
patients ankylosing
8
ankylosing spondylitis
8
database 2005
8
postoperative complication
8
thoracolumbar fusion
8
thoracolumbar fracture
8
thoracolumbar
5
patients
5

Similar Publications

Objective: Tumor consistency, or fibrosity, affects the ability to optimally resect meningiomas, especially with recent trends evolving toward minimally invasive approaches. The authors' team previously validated a practical 5-point scale for intraoperative grading of meningioma consistency. The impact of meningioma consistency on surgical management and outcomes, however, has yet to be explored.

View Article and Find Full Text PDF

Objective: Aneurysmal subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality rates. In particular, functional outcomes of SAH caused by large or giant (≥ 10 mm) ruptured intracranial aneurysms are worsened by high procedure-related complication rates. However, studies describing the risk factors for poor functional outcomes specific to ruptured large/giant aneurysms are sparse.

View Article and Find Full Text PDF

Objective: The goal of this study was to compare the impact of using a lower thoracic (LT) versus upper lumbar (UL) level as the upper instrumented vertebra (UIV) on clinical and radiographic outcomes following minimally invasive surgery for adult spinal deformity.

Methods: A multicenter retrospective study design was used. Inclusion criteria were age ≥ 18 years, and one of the following: coronal Cobb angle > 20°, sagittal vertical axis > 50 mm, pelvic tilt > 20°, pelvic incidence-lumbar lordosis mismatch > 10°.

View Article and Find Full Text PDF

Objective: To compare the 3-year outcomes of the modified minimally invasive Ponto surgery (m-MIPS) to both the original MIPS (o-MIPS) and linear incision technique with soft tissue preservation (LIT-TP) for inserting bone-anchored hearing implants (BAHIs).

Study Design: Prospective study with three patient groups: m-MIPS, o-MIPS, and LIT-TP.

Setting: Tertiary referral center.

View Article and Find Full Text PDF

Background: Belatacept is approved for the prophylaxis of organ rejection in Epstein-Barr virus (EBV)-seropositive kidney transplant recipients and is associated with a risk of post-transplant lymphoproliferative disorder (PTLD).

Methods: Data from the Organ Procurement and Transplantation Network were used to examine patterns of belatacept use, describe patient characteristics, and estimate risk of PTLD in EBV-seropositive, kidney-only transplant recipients receiving belatacept- or calcineurin inhibitor (CNI)-based immunosuppression as part of US Food and Drug Administration-mandated safety monitoring.

Results: During the study period (June 15, 2011-June 14, 2016), 94.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!